Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Todd Berner"'
Publikováno v:
BMC Immunology, Vol 21, Iss 1, Pp 1-15 (2020)
Abstract Background Often, patients with primary immunodeficiency diseases (PID), which are marked by the absence or loss of functional antibodies, require lifelong treatment with immunoglobulin (IG) replacement therapy administered either intravenou
Externí odkaz:
https://doaj.org/article/4242ba8d6c7243e0a8168c314f1fb0e5
Publikováno v:
Journal of Health Economics and Outcomes Research, Vol 3, Iss 1 (2016)
**Background:** Overactive bladder (OAB) is a chronic condition which may be associated with a significant negative impact on quality of life. Antimuscarinic drugs are currently the mainstay of medical therapy, but persistence and adherence are gener
Externí odkaz:
https://doaj.org/article/7f902d617f3740298dcab87ec9faf26e
Autor:
Anjay Rastogi, Sofia Schiavo, Dilip Makhija, Darrin Benjumea, Saba Gidey, Phil Mcewan, Silvia Rabar, Todd Berner
Publikováno v:
Nephrology Dialysis Transplantation. 37
BACKGROUND AND AIMS End-stage kidney disease (ESKD) is associated with a high clinical and economic burden. Dialysis modalities include in-center hemodialysis (ICHD) and home dialysis [home hemodialysis (HHD) or peritoneal dialysis (PD)]. The prevale
Publikováno v:
BMC Immunology, Vol 21, Iss 1, Pp 1-15 (2020)
BMC immunology, vol 21, iss 1
BMC Immunology
BMC immunology, vol 21, iss 1
BMC Immunology
Background Often, patients with primary immunodeficiency diseases (PID), which are marked by the absence or loss of functional antibodies, require lifelong treatment with immunoglobulin (IG) replacement therapy administered either intravenously (intr
Autor:
Georg F. Hoffmann, Mariarita Bertoldi, Riccardo Montioli, Beat Thöny, Nastassja Himmelreich, Nenad Blau, Corinne Gemperle, Vincenzo Leuzzi, Carla Borri Voltattorni, Todd Berner, Carla Carducci, Keith Hyland
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c262b8afdb1b7799a99f4f3db6d925f6
https://doi.org/10.5167/uzh-214659
https://doi.org/10.5167/uzh-214659
Autor:
Vincenzo Leuzzi, Beat Thöny, Todd Berner, Georg F. Hoffmann, Mariarita Bertoldi, Carla Carducci, Corinne Gemperle, Keith Hyland, Nenad Blau, Carla Borri Voltattorni, Riccardo Montioli, Nastassja Himmelreich
Publikováno v:
Web of Science
Aromatic- l -amino acid decarboxylase (AADC) deficiency is an ultra-rare inherited autosomal recessive disorder characterized by sharply reduced synthesis of dopamine as well as other neurotransmitters. Symptoms, including hypotonia and movement diso
Autor:
Todd Berner, Joseph G. Ouslander, Barbara J. Zarowitz, Carrie Allen, Terrence O'Shea, Eric G. Tangalos
Publikováno v:
The Consultant Pharmacist. 30:533-542
OBJECTIVE To identify clinical characteristics of residents with a diagnosis of overactive bladder (OAB) and/or urinary incontinence (UI) to determine the prevalence of comorbidities, severe mobility impairment (SMI), moderate-to-severe cognitive imp
Publikováno v:
Journal of Medical Economics. 17:741-750
To compare the healthcare costs of patients with overactive bladder (OAB) who switch vs persist on anti-muscarinic agents (AMs), describe resource use and costs among OAB patients who discontinue AMs, and assess factors associated with persisting vs
Autor:
Daniel B, Ng, Melissa, McCart, Christopher, Klein, Chelsey, Campbell, Robert, Schoenhaus, Todd, Berner
Publikováno v:
American healthdrug benefits. 9(6)
Overactive bladder (OAB) is a relatively common disease that has been linked to a variety of comorbidities, reductions in quality of life, and increased healthcare costs. Antimuscarinic agents are the standard of care among pharmacologic treatments f
Autor:
P M van Hagen, K. Boudjemia, Pauline M. Ellerbroek, Reinhold E. Schmidt, Leif G. Hanitsch, P. Van Paassen, Todd Berner, N. Nikolov, Leman Yel, Michael Borte
Publikováno v:
La Revue de Médecine Interne. 38:A165-A166
Introduction IgSCf est une Ig a 10 % associee avec la hyaluronidase humaine recombinante (rHuPH20) afin de faciliter la perfusion SC de l’IG, et approuvee dans l’union europeenne (UE) comme un traitement de substitution chez les adultes, enfants